WO2005055945A3 - Mucoadhesive drug delivery devices and methods of making and using thereof - Google Patents

Mucoadhesive drug delivery devices and methods of making and using thereof Download PDF

Info

Publication number
WO2005055945A3
WO2005055945A3 PCT/US2004/040975 US2004040975W WO2005055945A3 WO 2005055945 A3 WO2005055945 A3 WO 2005055945A3 US 2004040975 W US2004040975 W US 2004040975W WO 2005055945 A3 WO2005055945 A3 WO 2005055945A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug delivery
delivery devices
methods
mucoadhesive
making
Prior art date
Application number
PCT/US2004/040975
Other languages
French (fr)
Other versions
WO2005055945A2 (en
Inventor
David B Masters
Eric P Berg
Original Assignee
Gel Del Technologies Inc
David B Masters
Eric P Berg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gel Del Technologies Inc, David B Masters, Eric P Berg filed Critical Gel Del Technologies Inc
Priority to AU2004296851A priority Critical patent/AU2004296851A1/en
Priority to EP04813308.6A priority patent/EP1691746B1/en
Priority to CA2548822A priority patent/CA2548822C/en
Publication of WO2005055945A2 publication Critical patent/WO2005055945A2/en
Publication of WO2005055945A3 publication Critical patent/WO2005055945A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Abstract

The present invention relates to mucoadhesive drug delivery devices and their methods of preparation and use. More specifically the present invention relates to mucoadhesive drug delivery devices comprising one or more biocompatible purified proteins combined with one or more biocompatible solvents and one or more mucoadhesive agents. The mucoadhesive drug delivery devices may also include one or more pharmacologically active agents. The drug delivery devices of the present invention adhere to mucosal tissue, thereby providing a vehicle for delivery of the pharmacologically active agent(s) through such tissue.
PCT/US2004/040975 2003-12-08 2004-12-08 Mucoadhesive drug delivery devices and methods of making and using thereof WO2005055945A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2004296851A AU2004296851A1 (en) 2003-12-08 2004-12-08 Mucoadhesive drug delivery devices and methods of making and using thereof
EP04813308.6A EP1691746B1 (en) 2003-12-08 2004-12-08 Mucoadhesive drug delivery devices and methods of making and using thereof
CA2548822A CA2548822C (en) 2003-12-08 2004-12-08 Mucoadhesive drug delivery devices and methods of making and using thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52796203P 2003-12-08 2003-12-08
US60/527,962 2003-12-08

Publications (2)

Publication Number Publication Date
WO2005055945A2 WO2005055945A2 (en) 2005-06-23
WO2005055945A3 true WO2005055945A3 (en) 2005-08-25

Family

ID=34676802

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/040975 WO2005055945A2 (en) 2003-12-08 2004-12-08 Mucoadhesive drug delivery devices and methods of making and using thereof

Country Status (5)

Country Link
US (2) US8529939B2 (en)
EP (1) EP1691746B1 (en)
AU (1) AU2004296851A1 (en)
CA (1) CA2548822C (en)
WO (1) WO2005055945A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102851878A (en) * 2012-09-24 2013-01-02 淄博奈琦尔纺织科技发展有限公司 Alginate fiber absorbable medical auxiliary material and manufacture technology thereof

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
CN101005828B (en) * 2004-06-17 2012-01-11 维尔恩公司 Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
SI1848431T1 (en) 2005-02-09 2016-05-31 Santen Pharmaceutical Co., Ltd. Liquid formulations for treatment of diseases or conditions
US20060275369A1 (en) * 2005-06-01 2006-12-07 Cao Group, Inc. Orally Therapeutic Plastics and Devices Formed Therefrom
EP1937414A4 (en) * 2005-09-19 2013-01-02 Univ Witwatersrand Jhb Oramucosal pharmaceutical dosage form
US8137677B2 (en) * 2005-10-06 2012-03-20 Allergan, Inc. Non-protein stabilized clostridial toxin pharmaceutical compositions
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
JP5528708B2 (en) 2006-02-09 2014-06-25 参天製薬株式会社 Stable formulations and methods for preparing and using them
US8222271B2 (en) 2006-03-23 2012-07-17 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
EP2127631A4 (en) * 2007-02-28 2011-06-29 Tokuyama Dental Corp Adhesive agent for adhesion between alginate impression material for dental applications and impression tray, and kit comprising the adhesive agent
EP1972332A1 (en) * 2007-03-23 2008-09-24 BioAlliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
US20080292680A1 (en) * 2007-05-14 2008-11-27 Sustained Nano Systems Llc Hypercompressed polymer particles for controlled release ophthalmic medications
BRPI0819571A2 (en) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "method for emergency contraception, pharmaceutical package for emergency contraception and pharmaceutical composition"
BRPI0915386B8 (en) * 2008-06-23 2022-02-22 Biodelivery Sciences Int Inc Device for delivering an active agent through the mucosa
WO2010011597A2 (en) * 2008-07-22 2010-01-28 Mayo Foundation For Medical Education And Research Treatment of obesity and related disorders
EP2165706A1 (en) * 2008-09-18 2010-03-24 BioAlliance Pharma Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers.
WO2010042419A1 (en) * 2008-10-06 2010-04-15 Wm. Wrigley Jr. Company Chewing gum containing low dose amounts of water soluble vitamins
US20100098746A1 (en) * 2008-10-20 2010-04-22 Warsaw Orthopedic, Inc. Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone
KR101321615B1 (en) * 2009-03-27 2013-10-23 가부시키가이샤 마루하 니치로 쇼쿠힝 Crosslinked material comprising elastin and collagen, and use thereof
WO2011041483A2 (en) * 2009-09-30 2011-04-07 Toxcure, Inc. Use of botulinum neurotoxin to treat substance addictions
US8882748B2 (en) * 2009-10-08 2014-11-11 Palo Alto Research Center Incorporated Transmucosal drug delivery device and method including chemical permeation enhancers
EP3578205A1 (en) 2010-08-06 2019-12-11 ModernaTX, Inc. A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
CA2813466A1 (en) 2010-10-01 2012-04-05 Moderna Therapeutics, Inc. Modified nucleosides, nucleotides, and nucleic acids that disrupt major groove binding partner interactions
US10583033B2 (en) * 2011-02-04 2020-03-10 Katherine Rose Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
WO2012120516A1 (en) 2011-03-09 2012-09-13 Ramot At Tel-Aviv University Ltd. Soy protein-based structures and uses thereof
CA2831613A1 (en) 2011-03-31 2012-10-04 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
CN110511939A (en) 2011-10-03 2019-11-29 现代泰克斯公司 Nucleosides, nucleotide and nucleic acid of modification and application thereof
US9149528B2 (en) 2011-10-13 2015-10-06 Premier Dental Products Company Topical vitamin D oral supplement compositions
EP2791160B1 (en) 2011-12-16 2022-03-02 ModernaTX, Inc. Modified mrna compositions
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9878056B2 (en) 2012-04-02 2018-01-30 Modernatx, Inc. Modified polynucleotides for the production of cosmetic proteins and peptides
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
EP2833923A4 (en) 2012-04-02 2016-02-24 Moderna Therapeutics Inc Modified polynucleotides for the production of proteins
WO2013188979A1 (en) 2012-06-20 2013-12-27 Frank Gu Mucoadhesive nanoparticle delivery system
US9878000B2 (en) 2012-06-20 2018-01-30 University Of Waterloo Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
US9877930B2 (en) 2012-10-12 2018-01-30 Premier Dental Products Company Topical ubiquinol oral supplement compositions with amorphous calcium phosphate
US9724542B2 (en) 2012-10-12 2017-08-08 Premier Dental Products Company Remineralizing and desensitizing compositions, treatments and methods of manufacture
US20140113373A1 (en) * 2012-10-19 2014-04-24 Karen B. Chien Three dimensional soy protein-containing scaffolds and methods for their use and production
PT2922554T (en) 2012-11-26 2022-06-28 Modernatx Inc Terminally modified rna
WO2014144366A1 (en) * 2013-03-15 2014-09-18 Monosol Rx, Llc. Steroid hormone delivery systems and methods of preparing the same
US10029030B2 (en) * 2013-03-15 2018-07-24 Mimedx Group, Inc. Molded placental tissue compositions and methods of making and using the same
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
SG11201602503TA (en) 2013-10-03 2016-04-28 Moderna Therapeutics Inc Polynucleotides encoding low density lipoprotein receptor
US9334312B2 (en) 2013-10-04 2016-05-10 Rijksunviersiteit Groningen Biolubricant polypeptides and therapeutic uses thereof
US20160051495A1 (en) * 2014-08-20 2016-02-25 Professional Compounding Centers Of America Oral Transmucosal Compositions including C-SERMs for Low Testosterone Levels in Men
US20160051496A1 (en) * 2014-08-20 2016-02-25 Tsu-I Catherine Wang Oral Transmucosal Compositions Including C-SERMs for Treating Female Infertility
US9801983B2 (en) 2014-12-18 2017-10-31 Cook Medical Technologies Llc Medical devices for delivering a bioactive to a point of treatment and methods of making medical devices
TWI586381B (en) * 2015-01-13 2017-06-11 國立臺灣科技大學 Film with a hydrophobic drug, and its manufacturing method and use
SI3436054T2 (en) 2016-09-13 2022-09-30 Allergan, Inc. Stabilized non-protein clostridial toxin compositions
CN110505871B (en) * 2017-03-13 2023-08-15 纳米及先进材料研发院有限公司 High load rapidly disintegrating films for drug absorption
WO2018174938A1 (en) 2017-03-23 2018-09-27 Virun, Inc. Stable dry powders and emulsions containing probiotics and mucoadhesive protein
BR112019027366A2 (en) * 2017-06-22 2020-08-18 Viramal Limited compositions for drug delivery and methods of use
WO2019049145A1 (en) * 2017-09-11 2019-03-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods for nasal administration of drugs to brain and for systemic effect
WO2019110072A1 (en) * 2017-12-08 2019-06-13 Fertin Pharma A/S Nicotine tablet
CN107988301B (en) * 2018-01-11 2021-04-27 中国科学院新疆理化技术研究所 Preparation method and application of chickpea bean cotyledon polypeptide
CA3088728A1 (en) * 2018-01-21 2019-07-25 Bernie D. KASTNER Migraine treatment preparation and method
EP3845250B1 (en) * 2018-08-30 2022-07-06 FUJIFILM Corporation Biocompatible material
US10485632B1 (en) 2018-11-27 2019-11-26 King Saud University Intraoral attachment clip for attachment of objects to edentulous ridges
US20210106516A1 (en) * 2019-10-11 2021-04-15 Fertin Pharma A/S Ion-Exchange Composition With Water-Soluble Mucoadhesive Polymers
CN114558166B (en) * 2022-03-11 2022-12-13 中国医学科学院生物医学工程研究所 Biodegradable ultraviolet-curing medical adhesive and preparation method and application thereof
WO2023204734A1 (en) * 2022-04-21 2023-10-26 Общество С Ограниченной Ответственностью "Кинетик-Фарм" Means for intravaginal delivery of an active ingredient and method for producing and using same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385606A (en) * 1992-07-06 1995-01-31 Kowanko; Nicholas Adhesive composition and method

Family Cites Families (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996934A (en) 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3800792A (en) 1972-04-17 1974-04-02 Johnson & Johnson Laminated collagen film dressing
DE2843963A1 (en) 1978-10-09 1980-04-24 Merck Patent Gmbh BODY-RESORBABLE SHAPED MATERIAL BASED ON COLLAGEN AND THEIR USE IN MEDICINE
JPS5562012A (en) 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2042888B (en) 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4286592A (en) 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
JPS5758615A (en) 1980-09-26 1982-04-08 Nippon Soda Co Ltd Film agnent and its preparation
US4405311A (en) 1980-12-08 1983-09-20 Greatbatch Enterprises, Inc. Method and apparatus for direct electrical injection of gold ions into tissue such as bone
CA1204643A (en) 1981-09-16 1986-05-20 Hans I. Wallsten Device for application in blood vessels or other difficulty accessible locations and its use
US4394370A (en) 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
US4518721A (en) 1982-03-26 1985-05-21 Richardson-Vicks Inc. Hydrophilic denture adhesive
ATE37983T1 (en) 1982-04-22 1988-11-15 Ici Plc DELAYED RELEASE AGENT.
SE445884B (en) 1982-04-30 1986-07-28 Medinvent Sa DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
US4438253A (en) 1982-11-12 1984-03-20 American Cyanamid Company Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
US4718433A (en) 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4801299A (en) 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
JPS60100516A (en) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd Preparation of sustained release microcapsule
US4596574A (en) 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
USRE35748E (en) 1984-05-29 1998-03-17 Matrix Pharmaceutical, Inc. Treatments employing drug containing matrices for introduction into cellular lesion areas
US4580568A (en) 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4600533A (en) 1984-12-24 1986-07-15 Collagen Corporation Collagen membranes for medical use
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US5102417A (en) 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4780450A (en) 1985-12-20 1988-10-25 The University Of Maryland At Baltimore Physically stable composition and method of use thereof for osseous repair
ATE87469T1 (en) 1985-12-27 1993-04-15 Sumitomo Pharma PROCESS FOR THE MANUFACTURE OF A DELAYED RELEASE FORMULATION.
US4741872A (en) 1986-05-16 1988-05-03 The University Of Kentucky Research Foundation Preparation of biodegradable microspheres useful as carriers for macromolecules
US4959217A (en) 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4713243A (en) 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US5019372A (en) 1986-06-27 1991-05-28 The Children's Medical Center Corporation Magnetically modulated polymeric drug release system
US4706680A (en) 1986-06-30 1987-11-17 Nepera Inc. Conductive adhesive medical electrode assemblies
EP0258780B1 (en) 1986-09-05 1993-06-23 American Cyanamid Company Polyesters containing alkylene oxide blocks as drug delivery systems
JPH0744940B2 (en) 1986-12-24 1995-05-17 ライオン株式会社 Base material for oral application
US4907336A (en) 1987-03-13 1990-03-13 Cook Incorporated Method of making an endovascular stent and delivery system
US5041126A (en) 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
DE3714074A1 (en) 1987-04-28 1988-11-10 Hoechst Ag BASIS FOR MUCUTINE AND PROSTHESISAL PASTE, METHOD FOR THEIR PRODUCTION AND PASTE BASED ON THIS BASE
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
FR2616318A1 (en) 1987-06-15 1988-12-16 Centre Nat Rech Scient ARTIFICIAL SKIN AND PROCESS FOR PREPARING THE SAME
US4915948A (en) 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
US4917161A (en) 1987-10-06 1990-04-17 Helme Tobacco Company Chewing tobacco composition and process for producing the same
JP2670680B2 (en) 1988-02-24 1997-10-29 株式会社ビーエムジー Polylactic acid microspheres containing physiologically active substance and method for producing the same
US5041292A (en) 1988-08-31 1991-08-20 Theratech, Inc. Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents
US5145702A (en) * 1988-09-19 1992-09-08 Opta Food Ingredients, Inc. Hydrophobic protein microparticles and preparation thereof
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
JP2656338B2 (en) 1989-01-31 1997-09-24 日東電工株式会社 Oral mucosa patch preparation
US5037392A (en) 1989-06-06 1991-08-06 Cordis Corporation Stent-implanting balloon assembly
US5035706A (en) 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5147385A (en) 1989-11-01 1992-09-15 Schneider (Europe) A.G. Stent and catheter for the introduction of the stent
US5188837A (en) 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
US5298258A (en) 1989-12-28 1994-03-29 Nitto Denko Corporation Acrylic oily gel bioadhesive material and acrylic oily gel preparation
EP0521988B1 (en) 1990-03-30 1995-12-13 Alza Corporation Device for iontophoretic drug delivery
JP3046623B2 (en) 1990-06-14 2000-05-29 ヴィタフォア コーポレイション Polyurethane-biopolymer composite
DE69120177T2 (en) 1990-09-10 1996-10-10 Synthes Ag Bone regeneration membrane
ATE106015T1 (en) * 1990-09-28 1994-06-15 Pfizer METER DELIVERY DEVICE CONTAINING A HYDROPHOBIC AGENT.
DE69118083T2 (en) 1990-10-09 1996-08-22 Cook Inc Percutaneous stent assembly
JPH05192387A (en) 1990-11-08 1993-08-03 Matrix Pharmaceut Inc Fibrin for biomedical purpose/ collagenic coat
US5324261A (en) * 1991-01-04 1994-06-28 Medtronic, Inc. Drug delivery balloon catheter with line of weakness
CA2089487A1 (en) 1991-06-14 1992-12-15 Suk-Zu Song Collagen film drug delivery for proteins
US5330768A (en) 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5316023A (en) 1992-01-08 1994-05-31 Expandable Grafts Partnership Method for bilateral intra-aortic bypass
US5376376A (en) 1992-01-13 1994-12-27 Li; Shu-Tung Resorbable vascular wound dressings
US5573934A (en) 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
US5510077A (en) 1992-03-19 1996-04-23 Dinh; Thomas Q. Method of making an intraluminal stent
GB9206508D0 (en) 1992-03-25 1992-05-06 Jevco Ltd Biopolymer composites
WO1993021226A1 (en) 1992-04-10 1993-10-28 The General Hospital Corporation Cartilage matrix protein and methods for use
GB9211268D0 (en) 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
US5342387A (en) 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
GB2280850B (en) 1993-07-28 1997-07-30 Johnson & Johnson Medical Absorbable composite materials for use in the treatment of periodontal disease
DE4313192C1 (en) 1993-04-22 1994-09-15 Kirsch Axel Cuff for accelerating healing of bone defects
US5487895A (en) 1993-08-13 1996-01-30 Vitaphore Corporation Method for forming controlled release polymeric substrate
EP0717761A4 (en) 1993-08-19 1998-01-07 Cygnus Therapeutic Systems Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity
US6248110B1 (en) 1994-01-26 2001-06-19 Kyphon, Inc. Systems and methods for treating fractured or diseased bone using expandable bodies
US5518502A (en) * 1994-06-08 1996-05-21 The United States Surgical Corporation Compositions, methods and apparatus for inhibiting fogging of endoscope lenses
US5783214A (en) 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
GB9420355D0 (en) * 1994-10-10 1994-11-23 Univ Nottingham Preparation of protein microspheres, films and coatings
CA2202511A1 (en) * 1994-10-12 1996-04-25 Laurence A. Roth Targeted delivery via biodegradable polymers
CA2134997C (en) 1994-11-03 2009-06-02 Ian M. Penn Stent
CA2175720C (en) 1996-05-03 2011-11-29 Ian M. Penn Bifurcated stent and method for the manufacture and delivery of same
US6309671B1 (en) 1995-04-14 2001-10-30 Inhale Therapeutic Systems Stable glassy state powder formulations
US5776130A (en) 1995-09-19 1998-07-07 Valleylab, Inc. Vascular tissue sealing pressure control
US5773019A (en) 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5665428A (en) 1995-10-25 1997-09-09 Macromed, Inc. Preparation of peptide containing biodegradable microspheres by melt process
CN1052915C (en) 1995-11-27 2000-05-31 中国医学科学院生物医学工程研究所 Medical carrier of protein coat for carrying gene and its prodn. method
EP0876165B1 (en) 1995-12-18 2006-06-21 Angiotech BioMaterials Corp. Crosslinked polymer compositions and methods for their use
US5709683A (en) 1995-12-19 1998-01-20 Spine-Tech, Inc. Interbody bone implant having conjoining stabilization features for bony fusion
US5642749A (en) 1996-02-21 1997-07-01 Perryman; Joyce F. Crutch clutch holder
CA2175722A1 (en) 1996-05-03 1997-11-04 Ian M. Penn Expandable stent and method for delivery of same
EP1477133B9 (en) 1996-03-05 2007-11-21 Evysio Medical Devices Ulc Expandable stent
CA2185740A1 (en) 1996-09-17 1998-03-18 Ian M. Penn Expandable stent and method for delivery of same
CA2171047A1 (en) 1996-03-05 1997-09-06 Ian M. Penn Expandable stent and method for delivery of same
CA2192520A1 (en) 1996-03-05 1997-09-05 Ian M. Penn Expandable stent and method for delivery of same
US5948427A (en) 1996-04-25 1999-09-07 Point Medical Corporation Microparticulate surgical adhesive
US5834232A (en) 1996-05-01 1998-11-10 Zymogenetics, Inc. Cross-linked gelatin gels and methods of making them
JP2000511512A (en) 1996-05-03 2000-09-05 イノジェネティックス・ナムローゼ・フェンノートシャップ Novel pharmaceuticals containing gelatin crosslinked with oxidized polysaccharide
US6291582B1 (en) 1996-10-10 2001-09-18 Biotechnology Research & Development Corp. Polymer-protein composites and methods for their preparation and use
CA2269342C (en) 1996-10-23 2006-09-12 Sdgi Holdings, Inc. Spinal spacer
EP1723931B1 (en) 1996-11-04 2012-01-04 Advanced Stent Technologies, Inc. Extendible stent apparatus and method for deploying the same
EP0986408B1 (en) 1997-06-03 2005-05-11 Innogenetics N.V. New medicaments based on polymers composed of methacrylamide-modified gelatin
US6342250B1 (en) 1997-09-25 2002-01-29 Gel-Del Technologies, Inc. Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
GB9726916D0 (en) * 1997-12-19 1998-02-18 Danbiosyst Uk Nasal formulation
AU752879B2 (en) 1997-12-20 2002-10-03 Genencor International, Inc. Matrix granule
US6074689A (en) 1998-03-10 2000-06-13 Immucell Corporation Colonic delivery of protein or peptide compositions
US6287765B1 (en) 1998-05-20 2001-09-11 Molecular Machines, Inc. Methods for detecting and identifying single molecules
US6894022B1 (en) 1998-08-27 2005-05-17 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US7662409B2 (en) * 1998-09-25 2010-02-16 Gel-Del Technologies, Inc. Protein matrix materials, devices and methods of making and using thereof
US20030007991A1 (en) 1998-09-25 2003-01-09 Masters David B. Devices including protein matrix materials and methods of making and using thereof
US20050147690A1 (en) 1998-09-25 2005-07-07 Masters David B. Biocompatible protein particles, particle devices and methods thereof
DE60020526T2 (en) 1999-02-04 2006-05-11 SDGI Holdings, Inc., Wilmington OSTEOGENIC PASTE COMPOSITIONS AND THEIR USE
IT1312088B1 (en) * 1999-04-21 2002-04-04 Altergon Sa PATCH FOR TOPICAL USE CONTAINING HEPARIN AND DICLOFENAC.
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
AU4907901A (en) 2000-02-28 2001-11-26 Gel Del Technologies Inc Protein matrix materials, devices and methods of making and using thereof
MXPA02010758A (en) 2000-05-01 2005-05-31 Eth Zuerich Growth factor modified protein matrices for tissue engineering.
JP2004508884A (en) 2000-09-25 2004-03-25 コヒージョン　テクノロジーズ，　インコーポレイテッド Resorbable anastomotic stent and plug
US6517888B1 (en) 2000-11-28 2003-02-11 Scimed Life Systems, Inc. Method for manufacturing a medical device having a coated portion by laser ablation
AUPR272901A0 (en) * 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
US6716225B2 (en) 2001-08-02 2004-04-06 Collagen Matrix, Inc. Implant devices for nerve repair
KR20050011741A (en) * 2002-04-11 2005-01-29 메드이뮨 백신즈 인코포레이티드 Preservation of bioactive materials by spray drying
JP4463702B2 (en) 2004-04-28 2010-05-19 井原水産株式会社 Stretchable collagen molded body, production method and use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385606A (en) * 1992-07-06 1995-01-31 Kowanko; Nicholas Adhesive composition and method

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102851878A (en) * 2012-09-24 2013-01-02 淄博奈琦尔纺织科技发展有限公司 Alginate fiber absorbable medical auxiliary material and manufacture technology thereof

Also Published As

Publication number Publication date
EP1691746A2 (en) 2006-08-23
EP1691746A4 (en) 2010-11-17
US8529939B2 (en) 2013-09-10
CA2548822A1 (en) 2005-06-23
US20050196440A1 (en) 2005-09-08
CA2548822C (en) 2015-08-11
EP1691746B1 (en) 2015-05-27
WO2005055945A2 (en) 2005-06-23
AU2004296851A1 (en) 2005-06-23
US20140107227A1 (en) 2014-04-17

Similar Documents

Publication Publication Date Title
WO2005055945A3 (en) Mucoadhesive drug delivery devices and methods of making and using thereof
WO2004026231A3 (en) Formulation for lipophilic agents
WO2004089239A3 (en) Topical anthelmintic veterinary formulations
WO2003074551A3 (en) Conjugates of therapeutic or cytotoxic agents and biologically active peptides
WO2003072195A3 (en) Method for administering glp-1 molecules
WO2002083097A3 (en) Drug delivery system for hydrophobic drugs
WO2004082628A3 (en) Improved bioavailability and improved delivery of acidic pharmaceutical drugs
WO2006082588A3 (en) Method and device for ophthalmic administration of active pharmaceutical ingredients
WO2002070438A3 (en) Compositions for delivering bisphosphonates
WO2005120461A3 (en) Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
AU2003229084A1 (en) Methods and formulations for the delivery of pharmacologically active agents
WO2004021968A3 (en) Solution for ungual application
WO2003082247A3 (en) Drug microparticles
AU2003295614A1 (en) Delivery of pharmaceutical agents via the human insulin receptor
WO2008021088A3 (en) Salicylanilides enhance oral delivery of therapeutic peptides
MXPA03007590A (en) Compositions and methods for enhancing drug delivery across and into ocular tissues.
WO2003079972A3 (en) Active agent delivery systems and methods for protecting and administering active agents
WO2005102392A3 (en) Combinations for treating hiv infection
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2004100926A3 (en) Delivery of agents using hydrolyzable leaving groups
WO2000003753A3 (en) Microdisperse drug delivery systems
SG149872A1 (en) Antagonists of the bradykinin b1 receptor
WO2004066983A3 (en) Controlled release of highly soluble agents
WO2005044187A3 (en) Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
WO2004087167A3 (en) Pharmaceutical compositions comprising epinastine for the treatment of skin diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004296851

Country of ref document: AU

Ref document number: 2548822

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2004813308

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2004296851

Country of ref document: AU

Date of ref document: 20041208

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004296851

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2004813308

Country of ref document: EP